Global Opioid Induced Constipation Drugs Market Size, Status and Forecast 2022

Publisher Name :
Date: 03-Oct-2017
No. of pages: 100
Inquire Before Buying

This report studies the global Opioid Induced Constipation Drugs market, analyzes and researches the Opioid Induced Constipation Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like

- Ironwood Pharmaceuticals Inc

- Daiichi Sankyo Co Ltd

- Pfizer

- Progenics Pharmaceuticals Inc

- Shionogi & Co., Ltd

- Allergan Plc

- Nektar Therapeutics

- Purdue Pharma

- S.L.A. Pharma AG

- Mundipharma International Limited

- Ono Pharmaceutical Co., Ltd

- Takeda Pharmaceutical Company Limited

- Theravance Biopharma Inc

- Valeant Pharmaceuticals International

- Cosmo Pharmaceuticals SA

- Daewoong Pharmaceutical

- C.B. Fleet Company

- Sucampo Pharmaceuticals

Market segment by Regions/Countries, this report covers

- United States

- EU

- Japan

- China

- India

- Southeast Asia

Market segment by Type, Opioid Induced Constipation Drugs can be split into

- Lubiprostone

- Methyl Naltrexone Bromide

- Naldemedine

- Alvimopan

- Other

Market segment by Application, Opioid Induced Constipation Drugs can be split into

- Hospital Pharmacies

- Retail Pharmacies

- Online Pharmacies

If you have any special requirements, please let us know and we will offer you the report as you want.

Global Opioid Induced Constipation Drugs Market Size, Status and Forecast 2022

Table of Contents
Global Opioid Induced Constipation Drugs Market Size, Status and Forecast 2022
1 Industry Overview of Opioid Induced Constipation Drugs
1.1 Opioid Induced Constipation Drugs Market Overview
1.1.1 Opioid Induced Constipation Drugs Product Scope
1.1.2 Market Status and Outlook
1.2 Global Opioid Induced Constipation Drugs Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Opioid Induced Constipation Drugs Market by Type
1.3.1 Lubiprostone
1.3.2 Methyl Naltrexone Bromide
1.3.3 Naldemedine
1.3.4 Alvimopan
1.3.5 Other
1.4 Opioid Induced Constipation Drugs Market by End Users/Application
1.4.1 Hospital Pharmacies
1.4.2 Retail Pharmacies
1.4.3 Online Pharmacies
2 Global Opioid Induced Constipation Drugs Competition Analysis by Players
2.1 Opioid Induced Constipation Drugs Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 Ironwood Pharmaceuticals Inc
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Opioid Induced Constipation Drugs Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Daiichi Sankyo Co Ltd
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Opioid Induced Constipation Drugs Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 Pfizer
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Opioid Induced Constipation Drugs Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Progenics Pharmaceuticals Inc
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Opioid Induced Constipation Drugs Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Shionogi & Co., Ltd
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Opioid Induced Constipation Drugs Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Allergan Plc
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Opioid Induced Constipation Drugs Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Nektar Therapeutics
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Opioid Induced Constipation Drugs Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Purdue Pharma
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Opioid Induced Constipation Drugs Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 S.L.A. Pharma AG
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Opioid Induced Constipation Drugs Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Mundipharma International Limited
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Opioid Induced Constipation Drugs Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 Ono Pharmaceutical Co., Ltd
3.12 Takeda Pharmaceutical Company Limited
3.13 Theravance Biopharma Inc
3.14 Valeant Pharmaceuticals International
3.15 Cosmo Pharmaceuticals SA
3.16 Daewoong Pharmaceutical
3.17 C.B. Fleet Company
3.18 Sucampo Pharmaceuticals
4 Global Opioid Induced Constipation Drugs Market Size by Type and Application (2012-2017)
4.1 Global Opioid Induced Constipation Drugs Market Size by Type (2012-2017)
4.2 Global Opioid Induced Constipation Drugs Market Size by Application (2012-2017)
4.3 Potential Application of Opioid Induced Constipation Drugs in Future
4.4 Top Consumer/End Users of Opioid Induced Constipation Drugs
5 United States Opioid Induced Constipation Drugs Development Status and Outlook
5.1 United States Opioid Induced Constipation Drugs Market Size (2012-2017)
5.2 United States Opioid Induced Constipation Drugs Market Size and Market Share by Players (2016 and 2017)
6 EU Opioid Induced Constipation Drugs Development Status and Outlook
6.1 EU Opioid Induced Constipation Drugs Market Size (2012-2017)
6.2 EU Opioid Induced Constipation Drugs Market Size and Market Share by Players (2016 and 2017)
7 Japan Opioid Induced Constipation Drugs Development Status and Outlook
7.1 Japan Opioid Induced Constipation Drugs Market Size (2012-2017)
7.2 Japan Opioid Induced Constipation Drugs Market Size and Market Share by Players (2016 and 2017)
8 China Opioid Induced Constipation Drugs Development Status and Outlook
8.1 China Opioid Induced Constipation Drugs Market Size (2012-2017)
8.2 China Opioid Induced Constipation Drugs Market Size and Market Share by Players (2016 and 2017)
9 India Opioid Induced Constipation Drugs Development Status and Outlook
9.1 India Opioid Induced Constipation Drugs Market Size (2012-2017)
9.2 India Opioid Induced Constipation Drugs Market Size and Market Share by Players (2016 and 2017)
10 Southeast Asia Opioid Induced Constipation Drugs Development Status and Outlook
10.1 Southeast Asia Opioid Induced Constipation Drugs Market Size (2012-2017)
10.2 Southeast Asia Opioid Induced Constipation Drugs Market Size and Market Share by Players (2016 and 2017)
11 Market Forecast by Regions, Type and Application (2017-2022)
11.1 Global Opioid Induced Constipation Drugs Market Size (Value) by Regions (2017-2022)
11.1.1 United States Opioid Induced Constipation Drugs Revenue and Growth Rate (2017-2022)
11.1.2 EU Opioid Induced Constipation Drugs Revenue and Growth Rate (2017-2022)
11.1.3 Japan Opioid Induced Constipation Drugs Revenue and Growth Rate (2017-2022)
11.1.4 China Opioid Induced Constipation Drugs Revenue and Growth Rate (2017-2022)
11.1.5 India Opioid Induced Constipation Drugs Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Opioid Induced Constipation Drugs Revenue and Growth Rate (2017-2022)
11.2 Global Opioid Induced Constipation Drugs Market Size (Value) by Type (2017-2022)
11.3 Global Opioid Induced Constipation Drugs Market Size by Application (2017-2022)
12 Opioid Induced Constipation Drugs Market Dynamics
12.1 Opioid Induced Constipation Drugs Market Opportunities
12.2 Opioid Induced Constipation Drugs Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Opioid Induced Constipation Drugs Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Opioid Induced Constipation Drugs Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 Research Finding/Conclusion
15 Appendix
Methodology
Analyst Introduction
Data Source
List of Tables and Figures
Figure Opioid Induced Constipation Drugs Product Scope
Figure Global Opioid Induced Constipation Drugs Market Size (Million USD) (2012-2017)
Table Global Opioid Induced Constipation Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Opioid Induced Constipation Drugs Market Share by Regions in 2016
Figure United States Opioid Induced Constipation Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Opioid Induced Constipation Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Opioid Induced Constipation Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Opioid Induced Constipation Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Opioid Induced Constipation Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Opioid Induced Constipation Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Opioid Induced Constipation Drugs Market Share by Type in 2016
Figure Lubiprostone Market Size (Million USD) and Growth Rate (2012-2017)
Figure Methyl Naltrexone Bromide Market Size (Million USD) and Growth Rate (2012-2017)
Figure Naldemedine Market Size (Million USD) and Growth Rate (2012-2017)
Figure Alvimopan Market Size (Million USD) and Growth Rate (2012-2017)
Figure Other Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Opioid Induced Constipation Drugs Market Share by Application in 2016
Table Key Downstream Customer in Hospital Pharmacies
Figure Opioid Induced Constipation Drugs Market Size (Million USD) and Growth Rate in Hospital Pharmacies (2012-2017)
Table Key Downstream Customer in Retail Pharmacies
Figure Opioid Induced Constipation Drugs Market Size (Million USD) and Growth Rate in Retail Pharmacies (2012-2017)
Table Key Downstream Customer in Online Pharmacies
Figure Opioid Induced Constipation Drugs Market Size (Million USD) and Growth Rate in Online Pharmacies (2012-2017)
Table Opioid Induced Constipation Drugs Market Size (Million USD) by Players (2016 and 2017)
Figure Opioid Induced Constipation Drugs Market Size Share by Players in 2016
Figure Opioid Induced Constipation Drugs Market Size Share by Players in 2017
Table Ironwood Pharmaceuticals Inc Basic Information List
Table Opioid Induced Constipation Drugs Business Revenue (Million USD) of Ironwood Pharmaceuticals Inc (2012-2017)
Figure Ironwood Pharmaceuticals Inc Opioid Induced Constipation Drugs Business Revenue Market Share in 2016
Table Daiichi Sankyo Co Ltd Basic Information List
Table Opioid Induced Constipation Drugs Business Revenue (Million USD) of Daiichi Sankyo Co Ltd (2012-2017)
Figure Daiichi Sankyo Co Ltd Opioid Induced Constipation Drugs Business Revenue Market Share in 2016
Table Pfizer Basic Information List
Table Opioid Induced Constipation Drugs Business Revenue (Million USD) of Pfizer (2012-2017)
Figure Pfizer Opioid Induced Constipation Drugs Business Revenue Market Share in 2016
Table Progenics Pharmaceuticals Inc Basic Information List
Table Opioid Induced Constipation Drugs Business Revenue (Million USD) of Progenics Pharmaceuticals Inc (2012-2017)
Figure Progenics Pharmaceuticals Inc Opioid Induced Constipation Drugs Business Revenue Market Share in 2016
Table Shionogi & Co., Ltd Basic Information List
Table Opioid Induced Constipation Drugs Business Revenue (Million USD) of Shionogi & Co., Ltd (2012-2017)
Figure Shionogi & Co., Ltd Opioid Induced Constipation Drugs Business Revenue Market Share in 2016
Table Allergan Plc Basic Information List
Table Opioid Induced Constipation Drugs Business Revenue (Million USD) of Allergan Plc (2012-2017)
Figure Allergan Plc Opioid Induced Constipation Drugs Business Revenue Market Share in 2016
Table Nektar Therapeutics Basic Information List
Table Opioid Induced Constipation Drugs Business Revenue (Million USD) of Nektar Therapeutics (2012-2017)
Figure Nektar Therapeutics Opioid Induced Constipation Drugs Business Revenue Market Share in 2016
Table Purdue Pharma Basic Information List
Table Opioid Induced Constipation Drugs Business Revenue (Million USD) of Purdue Pharma (2012-2017)
Figure Purdue Pharma Opioid Induced Constipation Drugs Business Revenue Market Share in 2016
Table S.L.A. Pharma AG Basic Information List
Table Opioid Induced Constipation Drugs Business Revenue (Million USD) of S.L.A. Pharma AG (2012-2017)
Figure S.L.A. Pharma AG Opioid Induced Constipation Drugs Business Revenue Market Share in 2016
Table Mundipharma International Limited Basic Information List
Table Opioid Induced Constipation Drugs Business Revenue (Million USD) of Mundipharma International Limited (2012-2017)
Figure Mundipharma International Limited Opioid Induced Constipation Drugs Business Revenue Market Share in 2016
Table Ono Pharmaceutical Co., Ltd Basic Information List
Table Opioid Induced Constipation Drugs Business Revenue (Million USD) of Ono Pharmaceutical Co., Ltd (2012-2017)
Figure Ono Pharmaceutical Co., Ltd Opioid Induced Constipation Drugs Business Revenue Market Share in 2016
Table Takeda Pharmaceutical Company Limited Basic Information List
Table Opioid Induced Constipation Drugs Business Revenue (Million USD) of Takeda Pharmaceutical Company Limited (2012-2017)
Figure Takeda Pharmaceutical Company Limited Opioid Induced Constipation Drugs Business Revenue Market Share in 2016
Table Theravance Biopharma Inc Basic Information List
Table Opioid Induced Constipation Drugs Business Revenue (Million USD) of Theravance Biopharma Inc (2012-2017)
Figure Theravance Biopharma Inc Opioid Induced Constipation Drugs Business Revenue Market Share in 2016
Table Valeant Pharmaceuticals International Basic Information List
Table Opioid Induced Constipation Drugs Business Revenue (Million USD) of Valeant Pharmaceuticals International (2012-2017)
Figure Valeant Pharmaceuticals International Opioid Induced Constipation Drugs Business Revenue Market Share in 2016
Table Cosmo Pharmaceuticals SA Basic Information List
Table Opioid Induced Constipation Drugs Business Revenue (Million USD) of Cosmo Pharmaceuticals SA (2012-2017)
Figure Cosmo Pharmaceuticals SA Opioid Induced Constipation Drugs Business Revenue Market Share in 2016
Table Daewoong Pharmaceutical Basic Information List
Table Opioid Induced Constipation Drugs Business Revenue (Million USD) of Daewoong Pharmaceutical (2012-2017)
Figure Daewoong Pharmaceutical Opioid Induced Constipation Drugs Business Revenue Market Share in 2016
Table C.B. Fleet Company Basic Information List
Table Opioid Induced Constipation Drugs Business Revenue (Million USD) of C.B. Fleet Company (2012-2017)
Figure C.B. Fleet Company Opioid Induced Constipation Drugs Business Revenue Market Share in 2016
Table Sucampo Pharmaceuticals Basic Information List
Table Opioid Induced Constipation Drugs Business Revenue (Million USD) of Sucampo Pharmaceuticals (2012-2017)
Figure Sucampo Pharmaceuticals Opioid Induced Constipation Drugs Business Revenue Market Share in 2016
Table Global Opioid Induced Constipation Drugs Market Size (Million USD) by Type (2012-2017)
Figure Global Opioid Induced Constipation Drugs Market Size Share by Type in 2012
Figure Global Opioid Induced Constipation Drugs Market Size Share by Type in 2013
Figure Global Opioid Induced Constipation Drugs Market Size Share by Type in 2014
Figure Global Opioid Induced Constipation Drugs Market Size Share by Type in 2015
Figure Global Opioid Induced Constipation Drugs Market Size Share by Type in 2016
Figure Global Opioid Induced Constipation Drugs Market Size Share by Type in 2017
Table Global Opioid Induced Constipation Drugs Market Size (Million USD) by Application (2012-2017)
Figure Global Opioid Induced Constipation Drugs Market Size (Million USD) by Application in 2012
Figure Global Opioid Induced Constipation Drugs Market Size (Million USD) by Application in 2013
Figure Global Opioid Induced Constipation Drugs Market Size (Million USD) by Application in 2014
Figure Global Opioid Induced Constipation Drugs Market Size (Million USD) by Application in 2015
Figure Global Opioid Induced Constipation Drugs Market Size (Million USD) by Application in 2016
Figure Global Opioid Induced Constipation Drugs Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Opioid Induced Constipation Drugs
Figure United States Opioid Induced Constipation Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Opioid Induced Constipation Drugs Market Size (Million USD) by Players (2012-2017)
Figure United States Opioid Induced Constipation Drugs Market Size Share by Players in 2016
Figure United States Opioid Induced Constipation Drugs Market Size Share by Players in 2017
Figure EU Opioid Induced Constipation Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Opioid Induced Constipation Drugs Market Size (Million USD) by Players (2012-2017)
Figure EU Opioid Induced Constipation Drugs Market Size Share by Players in 2016
Figure EU Opioid Induced Constipation Drugs Market Size Share by Players in 2017
Figure Japan Opioid Induced Constipation Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Opioid Induced Constipation Drugs Market Size (Million USD) by Players (2012-2017)
Figure Japan Opioid Induced Constipation Drugs Market Size Share by Players in 2016
Figure Japan Opioid Induced Constipation Drugs Market Size Share by Players in 2017
Figure China Opioid Induced Constipation Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Opioid Induced Constipation Drugs Market Size (Million USD) by Players (2012-2017)
Figure China Opioid Induced Constipation Drugs Market Size Share by Players in 2016
Figure China Opioid Induced Constipation Drugs Market Size Share by Players in 2017
Figure India Opioid Induced Constipation Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Opioid Induced Constipation Drugs Market Size (Million USD) by Players (2012-2017)
Figure India Opioid Induced Constipation Drugs Market Size Share by Players in 2016
Figure India Opioid Induced Constipation Drugs Market Size Share by Players in 2017
Figure Southeast Asia Opioid Induced Constipation Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Opioid Induced Constipation Drugs Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Opioid Induced Constipation Drugs Market Size Share by Players in 2016
Figure Southeast Asia Opioid Induced Constipation Drugs Market Size Share by Players in 2017
Figure Global Opioid Induced Constipation Drugs Market Size (Million USD) by Regions (2017-2022)
Table Global Opioid Induced Constipation Drugs Market Size (Million USD) by Regions (2017-2022)
Figure Global Opioid Induced Constipation Drugs Market Size Share by Regions in 2017
Figure Global Opioid Induced Constipation Drugs Market Size Share by Regions in 2022
Figure United States Opioid Induced Constipation Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Opioid Induced Constipation Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Opioid Induced Constipation Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Opioid Induced Constipation Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Opioid Induced Constipation Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Opioid Induced Constipation Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Opioid Induced Constipation Drugs Market Size (Million USD) by Type (2017-2022)
Figure Global Opioid Induced Constipation Drugs Market Size Share by Type in 2017
Figure Global Opioid Induced Constipation Drugs Market Size Share by Type in 2022
Table Global Opioid Induced Constipation Drugs Market Size (Million USD) by Application (2017-2022)
Figure Global Opioid Induced Constipation Drugs Market Size (Million USD) by Application in 2017
Figure Global Opioid Induced Constipation Drugs Market Size (Million USD) by Application in 2022
  • Global Pizotifen Market Research Report 2018
    Published: 18-Jul-2018        Price: US 2900 Onwards        Pages: 99
    This report studies the global Pizotifen market status and forecast, categorizes the global Pizotifen market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. The global Pizotifen market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025. The major manufacturer......
  • Tyrosine Protein Kinase Receptor TYRO3 (Tyrosine Protein Kinase BYK or Tyrosine Protein Kinase DTK or Tyrosine Protein Kinase RSE or Tyrosine Protein Kinase TIF or Tyrosine Protein Kinase SKY or TYRO3 or EC 2.7.10.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 35
    Tyrosine Protein Kinase Receptor TYRO3 (Tyrosine Protein Kinase BYK or Tyrosine Protein Kinase DTK or Tyrosine Protein Kinase RSE or Tyrosine Protein Kinase TIF or Tyrosine Protein Kinase SKY or TYRO3 or EC 2.7.10.1) - Pipeline Review, H2 2018 Summary Tyrosine Protein Kinase Receptor TYRO3 (Tyrosine Protein Kinase BYK or Tyrosine Protein Kinase DTK or Tyrosine Protein Kinase RSE or Tyrosine Protein Kinase TIF or Tyrosine Protein Kinase SKY or TYRO3 or EC 2.7.10.1) pipel......
  • Protein Glutamine Gamma Glutamyltransferase 2 (Tissue Transglutaminase or Transglutaminase C or Transglutaminase H or Transglutaminase 2 or TGase C or TGase H or TGM2 or EC 2.3.2.13) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 37
    Protein Glutamine Gamma Glutamyltransferase 2 (Tissue Transglutaminase or Transglutaminase C or Transglutaminase H or Transglutaminase 2 or TGase C or TGase H or TGM2 or EC 2.3.2.13) - Pipeline Review, H2 2018 Summary Protein Glutamine Gamma Glutamyltransferase 2 (Tissue Transglutaminase or Transglutaminase C or Transglutaminase H or Transglutaminase 2 or TGase C or TGase H or TGM2 or EC 2.3.2.13) - Transglutaminase 2 (TG2) is a member of the transglutaminase family tha......
  • Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 40
    Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Pipeline Review, H2 2018 Summary Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Respiratory syncytial virus G protein is a protein produced by respiratory syncytial virus. It attaches the virion to the host cell membrane by interacting with heparan sulfate. It interacts with host CX3CR1, the receptor for the CX3C chemokine fractalkine, to modulate the immune response and facilitate in......
  • Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 70
    Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) - Pipeline Review, H2 2018 Summary Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) pipeline Target constitutes close to 15 molecules. Out of which approximately 9 molecules are developed by companies and remaining by the universities/institutes. The latest report Survival Motor Neuron Protein - Pipeline Review, H2 2018, outlays comprehensive information on the S......
  • NT 3 Growth Factor Receptor (TrkC Tyrosine Kinase or GP145 TrkC or Neurotrophic Tyrosine Kinase Receptor Type 3 or NTRK3 or EC 2.7.10.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 65
    NT 3 Growth Factor Receptor (TrkC Tyrosine Kinase or GP145 TrkC or Neurotrophic Tyrosine Kinase Receptor Type 3 or NTRK3 or EC 2.7.10.1) - Pipeline Review, H2 2018 Summary According to the recently published report 'NT 3 Growth Factor Receptor - Pipeline Review, H2 2018'; NT 3 Growth Factor Receptor (TrkC Tyrosine Kinase or GP145 TrkC or Neurotrophic Tyrosine Kinase Receptor Type 3 or NTRK3 or EC 2.7.10.1) pipeline Target constitutes close to 7 molecules. ......
  • MAP Kinase Interacting Serine/Threonine Protein Kinase 2 (MAP Kinase Signal Integrating Kinase 2 or MKNK2 or EC 2.7.11.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 41
    MAP Kinase Interacting Serine/Threonine Protein Kinase 2 (MAP Kinase Signal Integrating Kinase 2 or MKNK2 or EC 2.7.11.1) - Pipeline Review, H2 2018 Summary MAP Kinase Interacting Serine/Threonine Protein Kinase 2 (MAP Kinase Signal Integrating Kinase 2 or MKNK2 or EC 2.7.11.1) - MAP kinase-interacting serine/threonine-protein kinase 2 is an enzyme encoded by the MKNK2 gene. It phosphorylates SFPQ/PSF, HNRNPA1 and EIF4E. It plays a role in the response to environmental ......
  • BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK2 or EC 2.7.10.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 129
    BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK2 or EC 2.7.10.1) - Pipeline Review, H2 2018 Summary According to the recently published report 'BDNF NT 3 Growth Factors Receptor - Pipeline Review, H2 2018'; BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK......
  • Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 48
    Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) - Pipeline Review, H2 2018 Summary According to the recently published report 'Ephrin Type B Receptor 4 - Pipeline Review, H2 2018'; Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) pipeline Target constitutes close to 6 molecules. Out of which approximately 3 molecules are developed by compa......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs